NeuroSense Therapeutics (NRSN) Operating Leases (2022 - 2025)
NeuroSense Therapeutics' (NRSN) quarterly Operating Leases came in at $72000.0 in Q4 2025, down 1.37% year-over-year from $73000.0 in Q4 2024, and down 1.37% quarter-over-quarter from $73000.0 in Q4 2024.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Operating Leases (2022 - 2025) Analysis & Trends
NeuroSense Therapeutics has disclosed Operating Leases across 4 years of filings, most recently posting $72000.0 for Q4 2025.
- In Q4 2025, Operating Leases fell 1.37% year-over-year to $72000.0; the TTM figure through Dec 2025 stood at $72000.0 (down 1.37% YoY), while the FY2025 annual figure was $72000.0, down 1.37% from the prior year.
- Operating Leases came in at $72000.0 for Q4 2025 at NeuroSense Therapeutics, down from $73000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $207000.0 in Q1 2022 to a low of $19000.0 in Q3 2024.
- Average Operating Leases over 4 years is $104538.5, with a median of $84000.0 recorded in 2023.
- The largest YoY upside for Operating Leases was 0.0% in 2024 against a maximum downside of 77.38% in 2024.
- Over 4 years, Operating Leases stood at $147000.0 in 2022, then plunged by 50.34% to $73000.0 in 2023, then changed by 0.0% to $73000.0 in 2024, then declined by 1.37% to $72000.0 in 2025.
- Per Business Quant data, the three most recent Operating Leases figures were $72000.0 in Q4 2025, $73000.0 in Q4 2024, and $19000.0 in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn |
| 10 | NeuroSense Therapeutics | 8.09 Mn | 7.88 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 72,000.00 |
| Dec 31, 2024 | 73,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 36,000.00 |
| Mar 31, 2024 | 55,000.00 |
| Dec 31, 2023 | 73,000.00 |
| Sep 30, 2023 | 84,000.00 |
| Jun 30, 2023 | 104,000.00 |
| Mar 31, 2023 | 126,000.00 |
| Dec 31, 2022 | 147,000.00 |
| Sep 30, 2022 | 173,000.00 |
| Jun 30, 2022 | 190,000.00 |
| Mar 31, 2022 | 207,000.00 |
API Access
NeuroSense Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();